Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer

BACKGROUND: Current treatment methods for patients with triple-negative breast cancer (TNBC) are very limited, and the prognosis of TNBC is relatively poor. It has been reported that glucose transporter 1 (GLUT1) is overexpressed in breast cancer cells; however, its association with the prognosis is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaodan, Pang, Xiaocong, Zhang, Zhuo, Liu, Qianxin, Zhang, Hanxu, Xiang, Qian, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442321/
https://www.ncbi.nlm.nih.gov/pubmed/34525987
http://dx.doi.org/10.1186/s12885-021-08763-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442321/
https://www.ncbi.nlm.nih.gov/pubmed/34525987
http://dx.doi.org/10.1186/s12885-021-08763-y

Ejemplares similares